Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 7 - Drugs for disorders of the blood or the extracellular fluid
Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
10/1995
10/11/1995EP0675735A1 Method for modulating transendothelial migration of cells promoting inflammation, and related methods of measurement thereof
10/11/1995EP0506716B1 Method for the treatment of thrombocytopenia and pharmaceutical compositions useful therefor
10/11/1995CN1110056A Carbostyril derivatives
10/11/1995CN1109891A Methods for preventing degradation of protein C
10/11/1995CN1109754A Argatroban consentrated aqueous solution
10/11/1995CN1109751A Aqueous solution inclusion complexes of benzothiophene compounds with water soluble cyclodextrins, and pharmaceutical formulations and methods thereof
10/10/1995US5457205 Substituted thiazoles useful for treatment of diabetes
10/10/1995US5457118 Pyridine derived agents for cardiovascular diseases
10/10/1995US5457114 Antithrombin; antithrombotic, enzyme resistance, tolerability
10/10/1995US5457089 Muteins of human erythropoietin, the preparation thereof and the use thereof
10/10/1995US5456909 Used in therapy and diagnosis of inflammatory and immune disorders
10/10/1995CA1337297C Aminoacylates of glycerol acetal
10/05/1995WO1995026203A1 Wound healing
10/05/1995WO1995026202A1 Combinations of thrombolytically active proteins and anticoagulants, and uses thereof
10/05/1995WO1995026200A1 Enhanced virus-mediated dna transfer
10/05/1995WO1995026199A1 Covalent dimers of kit ligand and flt-3/flk-2 ligand
10/05/1995WO1995016452A3 Use of macrophage depleting agents for prolonging the survival of non-autologus hematopoietic cell transplants and animal model assay systems
10/05/1995CA2186496A1 Covalent dimers of kit ligand and flt-3/flk-2 ligand
10/05/1995CA2186390A1 Combinations of thrombolytically active proteins and anticoagulants, and uses thereof
10/04/1995EP0675201A1 Compositions and methods for stimulating megakaryocyte growth and differentiation
10/04/1995EP0675120A2 Use of ascorbyl-gamma-linolenate or a ascorbyl-dihomo-gamma-linolenate for the treatment of asthma, cancer, cardiovascular and inflammatory disorders
10/04/1995EP0674906A2 Thrombolytic agent containing plasmin and a plasminogen activator
10/04/1995EP0674632A1 Aminoacid derivatives of heterocycles as protein kinase c inhibitors
10/04/1995EP0674623A1 Bicyclic fibrinogen antagonists
10/03/1995US5455348 Anticoagulants
10/03/1995US5455338 Anticoagulants; protease inhibitors; thrombosis; surgery
10/03/1995US5455243 Fibrinogen receptor antagonists for inhibiting aggregation of blood platelets
10/03/1995US5455228 Peptidase resistant thrombin receptor peptide ligand
10/03/1995US5455181 Anticoagulant
10/01/1995CA2145841A1 Thrombosis agent
09/1995
09/28/1995WO1995025809A1 Compacted nucleic acids and their delivery to cells
09/28/1995WO1995025748A1 Topical fibrinogen complex
09/28/1995WO1995025721A1 New 1,4-disubstituted piperidine derivatives useful as medicaments acting on the glutamate receptor
09/28/1995WO1995025718A1 Vitamin-d amide derivatives
09/28/1995WO1995025443A1 Tocolytic oxytocin receptor antagonists
09/28/1995WO1995023860A3 KUNITZ DOMAIN INHIBITOR PROTEINS DERIVED FROM ALZHEIMER'S AMYLOID β-PROTEIN PRECURSOR INHIBITOR
09/28/1995DE4410822A1 Neue Piperidin-Derivate New piperidine derivatives
09/28/1995CA2186129A1 Tocolytic oxytocin receptor antagonists
09/28/1995CA2186010A1 New 1,4-disubstituted piperidine derivatives useful as medicaments acting on the glutamate receptor
09/28/1995CA2185813A1 Vitamin-d amide derivatives
09/28/1995CA2162997A1 Topical fibrinogen complex
09/27/1995EP0673936A1 Antithrombotic agents
09/27/1995EP0673388A1 Double chain peptide compounds having hemoregulatory activity
09/27/1995EP0673247A1 Fibrinogen receptor antagonists
09/27/1995EP0531548B1 Carbostyril derivatives as anti-thrombotic agents
09/27/1995CN1109055A 4-aminopyrimidine derivatives
09/27/1995CN1108932A Methods of increasing thrombemodulin expression
09/26/1995US5453430 1-[2-(arylsulphonylamino)-1-oxoethyl]piperidine derivatives, their preparation and their therapeutic application
09/26/1995US5453373 Protein C derivatives
09/26/1995US5453370 Method for the preparation of a phospholipid-dependent prothrombin activator from the venom of snakes
09/21/1995WO1995025091A2 Nipecotic acid derivatives as antithrombic compounds
09/21/1995WO1995024905A1 Use of triterpenesaponins, such as notoginsenoside r1 (r1) and/or astragaloside (iv) for preparing medicaments
09/21/1995CA2163027A1 Nipecotic acid derivatives as antithrombic compounds
09/20/1995EP0672665A1 Antithrombotic agents
09/20/1995EP0672659A1 Antithrombotic agents
09/20/1995EP0672658A1 Antithrombotic agents
09/20/1995EP0672657A1 Antithrombotic agents
09/20/1995EP0672145A1 Interleukin-3 (il-3) multiple mutation polypeptides
09/20/1995EP0672128A1 Stem cell proliferation factor
09/20/1995EP0672059A1 CYCLIC COMPOUNDS LINKED BY A HETEROCYCLIC RING USEFUL AS INHIBITORS OF PLATELET GLYCOPROTEIN IIb/IIIa
09/20/1995EP0672036A1 Pharmaceutically active diketopiperazines
09/20/1995EP0672034A1 Benzimidazole compounds which inhibit platelet aggregation
09/20/1995EP0671944A1 Bovine pancreatic trypsin inhibitor derived inhibitors of factor viia-tissue factor complex
09/20/1995EP0671931A1 Hemoregulatory peptides
09/20/1995EP0671924A1 Digitalis-like compounds
09/20/1995EP0671916A1 Transdermal administration system containing acetylsalicylic acid for antithrombotic therapy and the prevention of cancer
09/20/1995EP0671905A1 Stable protein: phospholipid compositions and methods
09/20/1995EP0563358B1 9-substituted bicyclo [3.3.0]octane derivatives, for use as txa2 antagonists
09/20/1995EP0489877B1 Antiatherosclerotic and antithrombotic 2-amino-6-phenyl-4h-pyran-4-ones
09/20/1995EP0326595B1 Peptides and antibodies that inhibit platelet adhesion
09/20/1995CN1108654A Methods of treating menstrual symtoms and compositions therefore
09/20/1995CN1108545A Quick blood-forming agent
09/19/1995US5451518 Purified human ceramide-activated protein kinase
09/19/1995US5451205 Remove and store portion of blood of patient, administer biocompatible oxygen carrier, return blood after patient has blood loss
09/19/1995CA1337072C 5-substituted [4,5-c] imidazopyridines
09/19/1995CA1337046C Thrombolytic agent
09/14/1995WO1995024427A1 Hybrid human/animal factor viii
09/14/1995WO1995024414A1 Fibroblast growth factor-10
09/14/1995WO1995024398A1 Isoxazoline compounds as inhibitors of tnf release
09/14/1995WO1995024393A1 Naphthalene derivatives as prostaglandin i2 agonists
09/14/1995WO1995024213A1 Method of stimulating hematopoiesis with hemoglobin
09/14/1995WO1995024189A1 Increasing fetal hemoglobin levels using carboxylic esters
09/14/1995CA2185327A1 Hybrid human/animal factor viii
09/14/1995CA2185104A1 Naphthalene derivatives as prostaglandin 12 agonists
09/14/1995CA2184695A1 Increasing fetal hemoglobin levels using carboxylic esters
09/14/1995CA2183961A1 Fibroblast growth factor-10
09/14/1995CA2182800A1 Method of stimulating hematopoiesis with hemoglobin
09/13/1995EP0671414A1 Antithrombotic
09/13/1995EP0671390A2 Antithrombotic agents
09/13/1995EP0670898A1 Interleukin-3 (il-3) mutant polypeptides
09/13/1995EP0542869B1 Tissue plasminogen activator variants with decreased clearance
09/13/1995EP0309456B1 Stromal tissue
09/13/1995CN1108248A Glycoprotein IIB/IIIA antagonists
09/13/1995CN1108137A Pharmaceutical compositions
09/12/1995US5449798 Phospholipid derivatives containing higher elements of the fifth group
09/12/1995US5449662 Atrial natriuretic peptide clearance inhibitors which resist degradation
09/08/1995WO1995023860A2 KUNITZ DOMAIN INHIBITOR PROTEINS DERIVED FROM ALZHEIMER'S AMYLOID β-PROTEIN PRECURSOR INHIBITOR
09/08/1995WO1995023809A1 Antithrombotic agents
09/08/1995WO1995023611A1 Products comprising substrates capable of enzymatic cross-linking
09/08/1995WO1995023609A1 Antithrombotic agents
1 ... 584 585 586 587 588 589 590 591 592 593 594 595 596 597 598 599 600 601 602 603 604 ... 671